Show simple item record

dc.contributor.authorBabaei, Hossein
dc.contributor.authorAzarmi, Yadollah
dc.date.accessioned2018-08-26T08:31:52Z
dc.date.available2018-08-26T08:31:52Z
dc.date.issued2008
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52215
dc.description.abstractStudies suggest that estrogen modulate vascular reactivity but at present its exact mechanism of action has yet to be clarified. The aim of this study was to evaluate the effect of 17?-estradiol (E2) on calcium-dependent and -independent contractions induced in the human saphenous veins (HSVs). HSVs were obtained from patients undergoing coronary artery bypass graft surgery. The ability of E2 to modulate Ca2+ entry was assessed by obtaining concentration-response curve to CaCl2 in the absence or presence of E2. In other experiments intracellular Ca2+ was depleted by repeated application of phenylephrine in the presence of cyclopiazonic acid (CPA). Then, at the plateau of PGF2? contraction, E2 or nifedipine (NIF) was added. Involvement of protein kinase C (PKC) in relaxant effect of E2 was evaluated by application of phorbol-12,13-dibutyrate (PDBu) in normal or Ca2+-free Krebs' solution. When the contraction was obtained, E2 or NIF was added. In Ca2+-free hyperpolarizing solution, pretreatment with E2, concentration dependently reduced contractions induced by cumulative addition of calcium chloride. Furthermore, E2 elicited relaxant effects on the PGF2?-induced contractions in Ca2+-free solution in the presence or absence of CPA. Both E2 and NIF produced significant relaxation in HSV rings contracted by direct activation of PKC in Krebs' solution. However, in Ca2+-free solution, NIF failed to induce relaxant effect but E2 kept its effect on the PDBu-induced contraction. These results suggest that the relaxant effect of E2 on HSV is elicited by calcium-dependent and -independent pathways. The calcium-independent pathway may involve PKC inhibition. é 2008 Elsevier Inc. All rights reserved.
dc.language.isoEnglish
dc.relation.ispartofSteroids
dc.subjectcalcium chloride
dc.subjectestradiol
dc.subjectnifedipine
dc.subjectphenylephrine
dc.subjectprostaglandin F2 alpha
dc.subjectprotein kinase C
dc.subjectcalcium
dc.subjectphorbol dibutyrate
dc.subjectadult
dc.subjectaged
dc.subjectarticle
dc.subjectconcentration response
dc.subjectcoronary artery bypass graft
dc.subjectdrug effect
dc.subjectenzyme activation
dc.subjectfemale
dc.subjecthuman
dc.subjecthuman tissue
dc.subjectmale
dc.subjectsaphenous vein
dc.subjectsignal transduction
dc.subjectvenoconstriction
dc.subjectdose response
dc.subjectin vitro study
dc.subjectmetabolism
dc.subjectmuscle contraction
dc.subjectphysiology
dc.subjectsaphenous vein
dc.subjectSimplexvirus
dc.subjectCalcium
dc.subjectDose-Response Relationship, Drug
dc.subjectEstradiol
dc.subjectHumans
dc.subjectMuscle Contraction
dc.subjectPhorbol 12,13-Dibutyrate
dc.subjectSaphenous Vein
dc.title17ß-Estradiol inhibits calcium-dependent and -independent contractions in isolated human saphenous vein
dc.typeArticle
dc.citation.volume73
dc.citation.issue8
dc.citation.spage844
dc.citation.epage850
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1016/j.steroids.2008.04.001


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record